Our results show that honokiol can effectively reverse the increase in NF-κB mRNA and protein expression in the hippocampi of LPS-treated depression model mice, suggesting that the improvement of LPS-induced depression-like behavior by honokiol may be related to the inhibition of NF-κB activation. The gene discussed is NFKB1; the disease is depressive disorder.